LI Hanjing,LI Shunan,ZHUO Zewei,et al.The Establishment of a Virus-related Lymphoma Risk Warning System and Health Management Model Based on Traditional Chinese Medicine Conditions[J].Journal of Traditional Chinese Medicine,2025,66(04):335-339.
LI Hanjing,LI Shunan,ZHUO Zewei,et al.The Establishment of a Virus-related Lymphoma Risk Warning System and Health Management Model Based on Traditional Chinese Medicine Conditions[J].Journal of Traditional Chinese Medicine,2025,66(04):335-339.DOI: 10.13288/j.11-2166/r.2025.04.002.
The Establishment of a Virus-related Lymphoma Risk Warning System and Health Management Model Based on Traditional Chinese Medicine Conditions
Virus-related lymphoma exhibits a dual nature as both a hematologic malignancy and a viral infectious disease, making it more resistant to treatment and associated with poorer prognosis. This paper analyzes the understanding and therapeutic advantages of traditional Chinese medicine (TCM) in virus-related lymphoma. It proposes a TCM-based approach centered around syndrome differentiation, using standardized measurements of the overall TCM condition, multi-omics research of hematologic tumors, and artificial intelligence technologies to identify the "pre-condition" of virus-related lymphoma. A risk warning model will be established to early identify high-risk populations with viral infections that may develop into malignant lymphoma, thereby establishing a risk warning system for virus-related lymphoma. At the same time, a TCM health management approach will be applied to manage and regulate virus-related lymphoma, interrupting its progression and forming a human-centered, comprehensive, continuous health service model. Based on this, a standardized, integrated clinical prevention and treatment decision-making model for virus-related lymphoma, recognized by both Chinese and western medicine, will be established to provide TCM solutions for primary prevention of major malignant tumors.
关键词
Keywords
references
GBD 2019 Diseases and Injuries Collaborators . Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019 [J]. Lancet , 2020 , 396 ( 10258 ): 1204 - 1222 .
ZHANG Y , GUO W , ZHAN Z , et al . Carcinogenic mechanisms of virus-associated lymphoma [J]. Front Immunol , 2024 , 15 : 1361009 . doi: 10.3389/fimmu.2024.1361009 http://dx.doi.org/10.3389/fimmu.2024.1361009 .
KUSUDA M , NAKASONE H , YOSHIMURA K , et al . Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients [J]. Br J Haematol , 2023 , 202 ( 3 ): 578 - 588 .
XIONG J , CUI BW , WANG N , et al . Genomic and transcriptomic characterization of natural killer T cell lymphoma [J]. Cancer Cell , 2020 , 37 ( 3 ): 403 - 419 .
ISHITSUKA K , TAMURA K . Human T-cell leukaemia virus type Ⅰ and adult T-cell leukaemia-lymphoma [J]. Lancet Oncol , 2014 , 15 ( 11 ): e517 - e526 .
HWANG J , SUH CH , WON KIM K , et al . The incidence of Epstein-Barr virus-positive diffuse large B-cell lymphoma: a systematic review and meta-analysis [J]. Cancers (Basel) , 2021 , 13 ( 8 ): 1785 .
MÜNZ C . Latency and lytic replication in Epstein-Barr virus-associated oncogenesis [J]. Nat Rev Microbiol , 2019 , 17 ( 11 ): 691 - 700 .
YAN Z , YAO Z , WANG H , et al . Plasma EBV-DNA and peripheral blood mononuclear cell EBV-DNA have disparate clinical relevance in patients with extranodal NK/T-cell lymphoma [J]. J Clin Virol , 2022 , 157 : 105320 . doi: 10.1016/j.jcv.2022.105320 http://dx.doi.org/10.1016/j.jcv.2022.105320 .